Invus Public Equities, L.P.'s Net Worth
-$123 Million
Who is Invus Public Equities, L.P.?
Invus Public Equities, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Omega Therapeutics, Inc., Seer, Inc., Generation Bio Co., LEXICON PHARMACEUTICALS, INC., ANTIGENICS INC /DE/, SQZ Biotechnologies Co, Scholar Rock Holding Corp, GLYCOMIMETICS INC, Furiex Pharmaceuticals, Inc., and NITROMED INC.
SEC CIK
Invus Public Equities, L.P.'s CIK is 0001340097
Past Insider Trading and Trends
2018 was Invus Public Equities, L.P.'s most active year for acquiring shares with 23 total transactions. Invus Public Equities, L.P.'s most active month to acquire stocks was the month of May. 2020 was Invus Public Equities, L.P.'s most active year for disposing of shares, totalling 8 transactions. Invus Public Equities, L.P.'s most active month to dispose stocks was the month of November. 2014 saw Invus Public Equities, L.P. paying a total of $149,999,999.65 for 149,253,731 shares, this is the most they've acquired in one year. In 2021 Invus Public Equities, L.P. cashed out on 5,252,545 shares for a total of $16,201,519.39, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Omega Therapeutics, Inc. (OMGA) Snapshot price: $3.625
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.27M |
$16.93 |
—
| 2.27M |
Jul 30 - Aug 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Seer, Inc. (SEER) Snapshot price: $1.78
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.32% | -252.54K |
$64.15 | -$16,201,519.39 | 5.59M |
Feb 1
| |||
Form 4
|
∞
| 5.84M |
$19.00 |
—
| 5.84M |
Dec 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Generation Bio Co. (GBIO) Snapshot price: $1.875
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.81M |
$19.00 |
—
| 2.81M |
Jun 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SQZ Biotechnologies Co (SQZB) Snapshot price: $0.0359
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.61M |
$16.00 |
—
| 1.61M |
Nov 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Scholar Rock Holding Corp (SRRK) Snapshot price: $16.145
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +24.28% | 2.2M |
$6.86 | $15,086,735.66 | 11.26M |
Oct 12
| |||
Form 4
| +0.35% | 31.56K |
$6.43 | $202,845.24 | 9.06M |
Apr 28
| |||
Form 4
| -0.01% | -1.09K |
$9.48 | -$10,373.31 | 9.03M |
Jan 9
| |||
Form 4
| +0.54% | 48.77K |
$9.33 | $455,090.68 | 9.03M |
Jan 5
| |||
Form 4
| +1.47% | 130.26K |
$8.04 | $1,047,382.71 | 8.98M |
Oct 25
| |||
Form 4
| +1.14% | 99.97K |
$7.60 | $759,548.75 | 8.85M |
Oct 3 - Oct 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 2.4M |
$14.00 | $6,300,000.00 | 2.4M |
May 29
| |||
| No matching records found | |||||||||